nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemifloxacin—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Gemifloxacin—Back pain—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Gemifloxacin—Dyspnoea—Leflunomide—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Gemifloxacin—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.001	0.001	CcSEcCtD
Gemifloxacin—Dyspepsia—Leflunomide—systemic scleroderma	0.000997	0.000997	CcSEcCtD
Gemifloxacin—Pancreatitis—Prednisone—systemic scleroderma	0.000997	0.000997	CcSEcCtD
Gemifloxacin—Vomiting—Mometasone—systemic scleroderma	0.000995	0.000995	CcSEcCtD
Gemifloxacin—Dry mouth—Lisinopril—systemic scleroderma	0.000993	0.000993	CcSEcCtD
Gemifloxacin—Rash—Mometasone—systemic scleroderma	0.000987	0.000987	CcSEcCtD
Gemifloxacin—Asthenia—Captopril—systemic scleroderma	0.000986	0.000986	CcSEcCtD
Gemifloxacin—Dermatitis—Mometasone—systemic scleroderma	0.000986	0.000986	CcSEcCtD
Gemifloxacin—Decreased appetite—Leflunomide—systemic scleroderma	0.000985	0.000985	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000984	0.000984	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000981	0.000981	CcSEcCtD
Gemifloxacin—Headache—Mometasone—systemic scleroderma	0.00098	0.00098	CcSEcCtD
Gemifloxacin—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000979	0.000979	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000978	0.000978	CcSEcCtD
Gemifloxacin—Insomnia—Mycophenolic acid—systemic scleroderma	0.000977	0.000977	CcSEcCtD
Gemifloxacin—Fatigue—Leflunomide—systemic scleroderma	0.000977	0.000977	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000973	0.000973	CcSEcCtD
Gemifloxacin—Oedema—Lisinopril—systemic scleroderma	0.000973	0.000973	CcSEcCtD
Gemifloxacin—Pruritus—Captopril—systemic scleroderma	0.000972	0.000972	CcSEcCtD
Gemifloxacin—Pain—Leflunomide—systemic scleroderma	0.000969	0.000969	CcSEcCtD
Gemifloxacin—Constipation—Leflunomide—systemic scleroderma	0.000969	0.000969	CcSEcCtD
Gemifloxacin—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000966	0.000966	CcSEcCtD
Gemifloxacin—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000963	0.000963	CcSEcCtD
Gemifloxacin—Somnolence—Mycophenolic acid—systemic scleroderma	0.000961	0.000961	CcSEcCtD
Gemifloxacin—Shock—Lisinopril—systemic scleroderma	0.000958	0.000958	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000953	0.000953	CcSEcCtD
Gemifloxacin—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000951	0.000951	CcSEcCtD
Gemifloxacin—Tachycardia—Lisinopril—systemic scleroderma	0.00095	0.00095	CcSEcCtD
Gemifloxacin—Body temperature increased—Azathioprine—systemic scleroderma	0.000948	0.000948	CcSEcCtD
Gemifloxacin—Abdominal pain—Azathioprine—systemic scleroderma	0.000948	0.000948	CcSEcCtD
Gemifloxacin—Skin disorder—Lisinopril—systemic scleroderma	0.000945	0.000945	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000941	0.000941	CcSEcCtD
Gemifloxacin—Diarrhoea—Captopril—systemic scleroderma	0.00094	0.00094	CcSEcCtD
Gemifloxacin—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000939	0.000939	CcSEcCtD
Gemifloxacin—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000939	0.000939	CcSEcCtD
Gemifloxacin—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000937	0.000937	CcSEcCtD
Gemifloxacin—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000935	0.000935	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000933	0.000933	CcSEcCtD
Gemifloxacin—Fatigue—Mycophenolic acid—systemic scleroderma	0.000932	0.000932	CcSEcCtD
Gemifloxacin—Nausea—Mometasone—systemic scleroderma	0.000929	0.000929	CcSEcCtD
Gemifloxacin—Anorexia—Lisinopril—systemic scleroderma	0.000928	0.000928	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000926	0.000926	CcSEcCtD
Gemifloxacin—Constipation—Mycophenolic acid—systemic scleroderma	0.000924	0.000924	CcSEcCtD
Gemifloxacin—Pain—Mycophenolic acid—systemic scleroderma	0.000924	0.000924	CcSEcCtD
Gemifloxacin—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000923	0.000923	CcSEcCtD
Gemifloxacin—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000918	0.000918	CcSEcCtD
Gemifloxacin—Hyperglycaemia—Prednisone—systemic scleroderma	0.000917	0.000917	CcSEcCtD
Gemifloxacin—Dizziness—Captopril—systemic scleroderma	0.000909	0.000909	CcSEcCtD
Gemifloxacin—Urticaria—Leflunomide—systemic scleroderma	0.0009	0.0009	CcSEcCtD
Gemifloxacin—Abdominal pain—Leflunomide—systemic scleroderma	0.000895	0.000895	CcSEcCtD
Gemifloxacin—Body temperature increased—Leflunomide—systemic scleroderma	0.000895	0.000895	CcSEcCtD
Gemifloxacin—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00089	0.00089	CcSEcCtD
Gemifloxacin—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00089	0.00089	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000888	0.000888	CcSEcCtD
Gemifloxacin—Breast disorder—Methotrexate—systemic scleroderma	0.000888	0.000888	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000887	0.000887	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000884	0.000884	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000883	0.000883	CcSEcCtD
Gemifloxacin—Insomnia—Lisinopril—systemic scleroderma	0.00088	0.00088	CcSEcCtD
Gemifloxacin—Vomiting—Captopril—systemic scleroderma	0.000874	0.000874	CcSEcCtD
Gemifloxacin—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00087	0.00087	CcSEcCtD
Gemifloxacin—Dyspnoea—Lisinopril—systemic scleroderma	0.000868	0.000868	CcSEcCtD
Gemifloxacin—Rash—Captopril—systemic scleroderma	0.000867	0.000867	CcSEcCtD
Gemifloxacin—Dermatitis—Captopril—systemic scleroderma	0.000866	0.000866	CcSEcCtD
Gemifloxacin—Somnolence—Lisinopril—systemic scleroderma	0.000865	0.000865	CcSEcCtD
Gemifloxacin—Headache—Captopril—systemic scleroderma	0.000861	0.000861	CcSEcCtD
Gemifloxacin—Dyspepsia—Lisinopril—systemic scleroderma	0.000857	0.000857	CcSEcCtD
Gemifloxacin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000854	0.000854	CcSEcCtD
Gemifloxacin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000854	0.000854	CcSEcCtD
Gemifloxacin—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000853	0.000853	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000853	0.000853	CcSEcCtD
Gemifloxacin—Decreased appetite—Lisinopril—systemic scleroderma	0.000846	0.000846	CcSEcCtD
Gemifloxacin—Eosinophilia—Methotrexate—systemic scleroderma	0.000841	0.000841	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00084	0.00084	CcSEcCtD
Gemifloxacin—Fatigue—Lisinopril—systemic scleroderma	0.000839	0.000839	CcSEcCtD
Gemifloxacin—Shock—Mycophenolate mofetil—systemic scleroderma	0.000839	0.000839	CcSEcCtD
Gemifloxacin—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000836	0.000836	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000835	0.000835	CcSEcCtD
Gemifloxacin—Pancreatitis—Methotrexate—systemic scleroderma	0.000833	0.000833	CcSEcCtD
Gemifloxacin—Pain—Lisinopril—systemic scleroderma	0.000832	0.000832	CcSEcCtD
Gemifloxacin—Constipation—Lisinopril—systemic scleroderma	0.000832	0.000832	CcSEcCtD
Gemifloxacin—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000832	0.000832	CcSEcCtD
Gemifloxacin—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000828	0.000828	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000824	0.000824	CcSEcCtD
Gemifloxacin—Diarrhoea—Azathioprine—systemic scleroderma	0.000821	0.000821	CcSEcCtD
Gemifloxacin—Haemoglobin—Prednisone—systemic scleroderma	0.000818	0.000818	CcSEcCtD
Gemifloxacin—Nausea—Captopril—systemic scleroderma	0.000816	0.000816	CcSEcCtD
Gemifloxacin—Haemorrhage—Prednisone—systemic scleroderma	0.000814	0.000814	CcSEcCtD
Gemifloxacin—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000813	0.000813	CcSEcCtD
Gemifloxacin—Asthenia—Leflunomide—systemic scleroderma	0.000813	0.000813	CcSEcCtD
Gemifloxacin—Pruritus—Leflunomide—systemic scleroderma	0.000801	0.000801	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Prednisone—systemic scleroderma	0.0008	0.0008	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000796	0.000796	CcSEcCtD
Gemifloxacin—Dizziness—Azathioprine—systemic scleroderma	0.000793	0.000793	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000777	0.000777	CcSEcCtD
Gemifloxacin—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000775	0.000775	CcSEcCtD
Gemifloxacin—Asthenia—Mycophenolic acid—systemic scleroderma	0.000775	0.000775	CcSEcCtD
Gemifloxacin—Diarrhoea—Leflunomide—systemic scleroderma	0.000775	0.000775	CcSEcCtD
Gemifloxacin—Urticaria—Lisinopril—systemic scleroderma	0.000773	0.000773	CcSEcCtD
Gemifloxacin—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000771	0.000771	CcSEcCtD
Gemifloxacin—Body temperature increased—Lisinopril—systemic scleroderma	0.000769	0.000769	CcSEcCtD
Gemifloxacin—Abdominal pain—Lisinopril—systemic scleroderma	0.000769	0.000769	CcSEcCtD
Gemifloxacin—Pruritus—Mycophenolic acid—systemic scleroderma	0.000765	0.000765	CcSEcCtD
Gemifloxacin—Vomiting—Azathioprine—systemic scleroderma	0.000763	0.000763	CcSEcCtD
Gemifloxacin—Pneumonia—Methotrexate—systemic scleroderma	0.000762	0.000762	CcSEcCtD
Gemifloxacin—Eye disorder—Prednisone—systemic scleroderma	0.00076	0.00076	CcSEcCtD
Gemifloxacin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00076	0.00076	CcSEcCtD
Gemifloxacin—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000758	0.000758	CcSEcCtD
Gemifloxacin—Infestation NOS—Methotrexate—systemic scleroderma	0.000757	0.000757	CcSEcCtD
Gemifloxacin—Infestation—Methotrexate—systemic scleroderma	0.000757	0.000757	CcSEcCtD
Gemifloxacin—Rash—Azathioprine—systemic scleroderma	0.000756	0.000756	CcSEcCtD
Gemifloxacin—Dermatitis—Azathioprine—systemic scleroderma	0.000756	0.000756	CcSEcCtD
Gemifloxacin—Flushing—Prednisone—systemic scleroderma	0.000755	0.000755	CcSEcCtD
Gemifloxacin—Headache—Azathioprine—systemic scleroderma	0.000751	0.000751	CcSEcCtD
Gemifloxacin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000751	0.000751	CcSEcCtD
Gemifloxacin—Dizziness—Leflunomide—systemic scleroderma	0.000749	0.000749	CcSEcCtD
Gemifloxacin—Renal failure—Methotrexate—systemic scleroderma	0.000745	0.000745	CcSEcCtD
Gemifloxacin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000741	0.000741	CcSEcCtD
Gemifloxacin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000739	0.000739	CcSEcCtD
Gemifloxacin—Stomatitis—Methotrexate—systemic scleroderma	0.000738	0.000738	CcSEcCtD
Gemifloxacin—Angiopathy—Prednisone—systemic scleroderma	0.000738	0.000738	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000736	0.000736	CcSEcCtD
Gemifloxacin—Immune system disorder—Prednisone—systemic scleroderma	0.000735	0.000735	CcSEcCtD
Gemifloxacin—Pain—Mycophenolate mofetil—systemic scleroderma	0.000729	0.000729	CcSEcCtD
Gemifloxacin—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000729	0.000729	CcSEcCtD
Gemifloxacin—Haematuria—Methotrexate—systemic scleroderma	0.000722	0.000722	CcSEcCtD
Gemifloxacin—Vomiting—Leflunomide—systemic scleroderma	0.00072	0.00072	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000716	0.000716	CcSEcCtD
Gemifloxacin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000715	0.000715	CcSEcCtD
Gemifloxacin—Rash—Leflunomide—systemic scleroderma	0.000714	0.000714	CcSEcCtD
Gemifloxacin—Dermatitis—Leflunomide—systemic scleroderma	0.000714	0.000714	CcSEcCtD
Gemifloxacin—Mental disorder—Prednisone—systemic scleroderma	0.000713	0.000713	CcSEcCtD
Gemifloxacin—Nausea—Azathioprine—systemic scleroderma	0.000712	0.000712	CcSEcCtD
Gemifloxacin—Headache—Leflunomide—systemic scleroderma	0.00071	0.00071	CcSEcCtD
Gemifloxacin—Agranulocytosis—Methotrexate—systemic scleroderma	0.000707	0.000707	CcSEcCtD
Gemifloxacin—Asthenia—Lisinopril—systemic scleroderma	0.000698	0.000698	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000697	0.000697	CcSEcCtD
Gemifloxacin—Pruritus—Lisinopril—systemic scleroderma	0.000689	0.000689	CcSEcCtD
Gemifloxacin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000687	0.000687	CcSEcCtD
Gemifloxacin—Haemoglobin—Methotrexate—systemic scleroderma	0.000683	0.000683	CcSEcCtD
Gemifloxacin—Rash—Mycophenolic acid—systemic scleroderma	0.000681	0.000681	CcSEcCtD
Gemifloxacin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000681	0.000681	CcSEcCtD
Gemifloxacin—Haemorrhage—Methotrexate—systemic scleroderma	0.00068	0.00068	CcSEcCtD
Gemifloxacin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000677	0.000677	CcSEcCtD
Gemifloxacin—Headache—Mycophenolic acid—systemic scleroderma	0.000677	0.000677	CcSEcCtD
Gemifloxacin—Pharyngitis—Methotrexate—systemic scleroderma	0.000675	0.000675	CcSEcCtD
Gemifloxacin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000674	0.000674	CcSEcCtD
Gemifloxacin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000674	0.000674	CcSEcCtD
Gemifloxacin—Nausea—Leflunomide—systemic scleroderma	0.000673	0.000673	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000672	0.000672	CcSEcCtD
Gemifloxacin—Urethral disorder—Methotrexate—systemic scleroderma	0.000667	0.000667	CcSEcCtD
Gemifloxacin—Diarrhoea—Lisinopril—systemic scleroderma	0.000666	0.000666	CcSEcCtD
Gemifloxacin—Visual impairment—Methotrexate—systemic scleroderma	0.000655	0.000655	CcSEcCtD
Gemifloxacin—Anaemia—Prednisone—systemic scleroderma	0.000655	0.000655	CcSEcCtD
Gemifloxacin—Dizziness—Lisinopril—systemic scleroderma	0.000644	0.000644	CcSEcCtD
Gemifloxacin—Erythema multiforme—Methotrexate—systemic scleroderma	0.000643	0.000643	CcSEcCtD
Gemifloxacin—Nausea—Mycophenolic acid—systemic scleroderma	0.000642	0.000642	CcSEcCtD
Gemifloxacin—Vertigo—Prednisone—systemic scleroderma	0.000636	0.000636	CcSEcCtD
Gemifloxacin—Eye disorder—Methotrexate—systemic scleroderma	0.000635	0.000635	CcSEcCtD
Gemifloxacin—Syncope—Prednisone—systemic scleroderma	0.000635	0.000635	CcSEcCtD
Gemifloxacin—Cardiac disorder—Methotrexate—systemic scleroderma	0.000631	0.000631	CcSEcCtD
Gemifloxacin—Loss of consciousness—Prednisone—systemic scleroderma	0.000623	0.000623	CcSEcCtD
Gemifloxacin—Vomiting—Lisinopril—systemic scleroderma	0.000619	0.000619	CcSEcCtD
Gemifloxacin—Angiopathy—Methotrexate—systemic scleroderma	0.000617	0.000617	CcSEcCtD
Gemifloxacin—Immune system disorder—Methotrexate—systemic scleroderma	0.000614	0.000614	CcSEcCtD
Gemifloxacin—Rash—Lisinopril—systemic scleroderma	0.000614	0.000614	CcSEcCtD
Gemifloxacin—Dermatitis—Lisinopril—systemic scleroderma	0.000613	0.000613	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000613	0.000613	CcSEcCtD
Gemifloxacin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000612	0.000612	CcSEcCtD
Gemifloxacin—Headache—Lisinopril—systemic scleroderma	0.00061	0.00061	CcSEcCtD
Gemifloxacin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000603	0.000603	CcSEcCtD
Gemifloxacin—Arthralgia—Prednisone—systemic scleroderma	0.000603	0.000603	CcSEcCtD
Gemifloxacin—Myalgia—Prednisone—systemic scleroderma	0.000603	0.000603	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000599	0.000599	CcSEcCtD
Gemifloxacin—Mental disorder—Methotrexate—systemic scleroderma	0.000596	0.000596	CcSEcCtD
Gemifloxacin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000583	0.000583	CcSEcCtD
Gemifloxacin—Dysgeusia—Methotrexate—systemic scleroderma	0.00058	0.00058	CcSEcCtD
Gemifloxacin—Nausea—Lisinopril—systemic scleroderma	0.000578	0.000578	CcSEcCtD
Gemifloxacin—Oedema—Prednisone—systemic scleroderma	0.000578	0.000578	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Prednisone—systemic scleroderma	0.000578	0.000578	CcSEcCtD
Gemifloxacin—Back pain—Methotrexate—systemic scleroderma	0.000573	0.000573	CcSEcCtD
Gemifloxacin—Shock—Prednisone—systemic scleroderma	0.000569	0.000569	CcSEcCtD
Gemifloxacin—Nervous system disorder—Prednisone—systemic scleroderma	0.000567	0.000567	CcSEcCtD
Gemifloxacin—Tachycardia—Prednisone—systemic scleroderma	0.000564	0.000564	CcSEcCtD
Gemifloxacin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000564	0.000564	CcSEcCtD
Gemifloxacin—Skin disorder—Prednisone—systemic scleroderma	0.000561	0.000561	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Prednisone—systemic scleroderma	0.000559	0.000559	CcSEcCtD
Gemifloxacin—Anorexia—Prednisone—systemic scleroderma	0.000551	0.000551	CcSEcCtD
Gemifloxacin—Anaemia—Methotrexate—systemic scleroderma	0.000547	0.000547	CcSEcCtD
Gemifloxacin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000542	0.000542	CcSEcCtD
Gemifloxacin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000538	0.000538	CcSEcCtD
Gemifloxacin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000537	0.000537	CcSEcCtD
Gemifloxacin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000534	0.000534	CcSEcCtD
Gemifloxacin—Vertigo—Methotrexate—systemic scleroderma	0.000532	0.000532	CcSEcCtD
Gemifloxacin—Leukopenia—Methotrexate—systemic scleroderma	0.00053	0.00053	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000527	0.000527	CcSEcCtD
Gemifloxacin—Insomnia—Prednisone—systemic scleroderma	0.000523	0.000523	CcSEcCtD
Gemifloxacin—Dyspepsia—Prednisone—systemic scleroderma	0.000509	0.000509	CcSEcCtD
Gemifloxacin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000507	0.000507	CcSEcCtD
Gemifloxacin—Arthralgia—Methotrexate—systemic scleroderma	0.000504	0.000504	CcSEcCtD
Gemifloxacin—Myalgia—Methotrexate—systemic scleroderma	0.000504	0.000504	CcSEcCtD
Gemifloxacin—Decreased appetite—Prednisone—systemic scleroderma	0.000502	0.000502	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.0005	0.0005	CcSEcCtD
Gemifloxacin—Fatigue—Prednisone—systemic scleroderma	0.000498	0.000498	CcSEcCtD
Gemifloxacin—Constipation—Prednisone—systemic scleroderma	0.000494	0.000494	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000483	0.000483	CcSEcCtD
Gemifloxacin—Nervous system disorder—Methotrexate—systemic scleroderma	0.000474	0.000474	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000473	0.000473	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000473	0.000473	CcSEcCtD
Gemifloxacin—Skin disorder—Methotrexate—systemic scleroderma	0.000469	0.000469	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000467	0.000467	CcSEcCtD
Gemifloxacin—Anorexia—Methotrexate—systemic scleroderma	0.00046	0.00046	CcSEcCtD
Gemifloxacin—Urticaria—Prednisone—systemic scleroderma	0.000459	0.000459	CcSEcCtD
Gemifloxacin—Abdominal pain—Prednisone—systemic scleroderma	0.000457	0.000457	CcSEcCtD
Gemifloxacin—Body temperature increased—Prednisone—systemic scleroderma	0.000457	0.000457	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.00044	0.00044	CcSEcCtD
Gemifloxacin—Insomnia—Methotrexate—systemic scleroderma	0.000437	0.000437	CcSEcCtD
Gemifloxacin—Dyspnoea—Methotrexate—systemic scleroderma	0.000431	0.000431	CcSEcCtD
Gemifloxacin—Somnolence—Methotrexate—systemic scleroderma	0.000429	0.000429	CcSEcCtD
Gemifloxacin—Dyspepsia—Methotrexate—systemic scleroderma	0.000425	0.000425	CcSEcCtD
Gemifloxacin—Decreased appetite—Methotrexate—systemic scleroderma	0.00042	0.00042	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000417	0.000417	CcSEcCtD
Gemifloxacin—Fatigue—Methotrexate—systemic scleroderma	0.000417	0.000417	CcSEcCtD
Gemifloxacin—Asthenia—Prednisone—systemic scleroderma	0.000415	0.000415	CcSEcCtD
Gemifloxacin—Pain—Methotrexate—systemic scleroderma	0.000413	0.000413	CcSEcCtD
Gemifloxacin—Pruritus—Prednisone—systemic scleroderma	0.000409	0.000409	CcSEcCtD
Gemifloxacin—Diarrhoea—Prednisone—systemic scleroderma	0.000396	0.000396	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000395	0.000395	CcSEcCtD
Gemifloxacin—Urticaria—Methotrexate—systemic scleroderma	0.000384	0.000384	CcSEcCtD
Gemifloxacin—Dizziness—Prednisone—systemic scleroderma	0.000382	0.000382	CcSEcCtD
Gemifloxacin—Abdominal pain—Methotrexate—systemic scleroderma	0.000382	0.000382	CcSEcCtD
Gemifloxacin—Body temperature increased—Methotrexate—systemic scleroderma	0.000382	0.000382	CcSEcCtD
Gemifloxacin—Vomiting—Prednisone—systemic scleroderma	0.000368	0.000368	CcSEcCtD
Gemifloxacin—Rash—Prednisone—systemic scleroderma	0.000364	0.000364	CcSEcCtD
Gemifloxacin—Dermatitis—Prednisone—systemic scleroderma	0.000364	0.000364	CcSEcCtD
Gemifloxacin—Headache—Prednisone—systemic scleroderma	0.000362	0.000362	CcSEcCtD
Gemifloxacin—Asthenia—Methotrexate—systemic scleroderma	0.000347	0.000347	CcSEcCtD
Gemifloxacin—Nausea—Prednisone—systemic scleroderma	0.000343	0.000343	CcSEcCtD
Gemifloxacin—Pruritus—Methotrexate—systemic scleroderma	0.000342	0.000342	CcSEcCtD
Gemifloxacin—Diarrhoea—Methotrexate—systemic scleroderma	0.000331	0.000331	CcSEcCtD
Gemifloxacin—Dizziness—Methotrexate—systemic scleroderma	0.000319	0.000319	CcSEcCtD
Gemifloxacin—Vomiting—Methotrexate—systemic scleroderma	0.000307	0.000307	CcSEcCtD
Gemifloxacin—Rash—Methotrexate—systemic scleroderma	0.000305	0.000305	CcSEcCtD
Gemifloxacin—Dermatitis—Methotrexate—systemic scleroderma	0.000304	0.000304	CcSEcCtD
Gemifloxacin—Headache—Methotrexate—systemic scleroderma	0.000303	0.000303	CcSEcCtD
Gemifloxacin—Nausea—Methotrexate—systemic scleroderma	0.000287	0.000287	CcSEcCtD
